| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jun―24 |
Neurocognitive and psychiatric outcomes associated with postacute COVID-19 infection without severe medical complication: a meta-analysis |
Sarah A B Knapp, David S Austin, Stephen L Aita, Joshua E Caron, Tyler Owen, Nicholas C Borgogna, Victor A Del Bene, Robert M Roth, William P Milberg, Benjamin D Hill |
| 2 |
[GO] |
2024―Mar―28 |
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccination |
Niels J M Verstegen, Ruth R Hagen, Christine Kreher, Lisan H Kuijper, Jet van den Dijssel, Thomas Ashhurst, Laura Y L Kummer, Virginia Palomares Cabeza, Maurice Steenhuis, Mariël C Duurland, Rivka de Jongh, C Ellen van der Schoot, Veronique A L Konijn, Erik Mul, Katherine Kedzierska, Koos P J van Dam, Eileen W Stalman, Laura Boekel, Gertjan Wolbink, Sander W Tas, Joep Killestein, Theo Rispens, Luuk Wieske, Taco W Kuijpers, Filip Eftimov, Zoé L E van Kempen, S Marieke van Ham, Anja ten Brinke, Carolien E van de Sandt |
| 3 |
[GO] |
2023―Oct―26 |
Using qualitative free-text data to investigate the lived experience of the COVID-19 pandemic for a large cohort of Australians with different multiple sclerosis related disability levels |
Julie A Campbell, Ingrid van der Mei, Bruce V Taylor, Andrew J Palmer, Glen J Henson, Laura Louise Laslett, Steve Simpson-Yap, Suzi B Claflin |
| 4 |
[GO] |
2023―Oct―19 |
COVID-19 has no impact on disease activity, progression and cognitive performance in people with multiple sclerosis: a 2-year study |
Federico Montini, Agostino Nozzolillo, Nicolò Tedone, Damiano Mistri, Paola MV Rancoita, Chiara Zanetta, Alessandra Mandelli, Roberto Furlan, Lucia Moiola, Vittorio Martinelli, Maria A Rocca, Massimo Filippi |
| 5 |
[GO] |
2023―Jul―21 |
Is vaccine response to SARS-CoV-2 preserved after switching to anti-CD20 therapies in patients with multiple sclerosis or related disorders? |
Lina Jeantin, Basma Abdi, Cathia Soulié, Delphine Sterlin, Elisabeth Maillart, Ysoline Beigneux, Amandine Hippolyte, Lisa Belin, Anne-Geneviève Marcelin, Valérie Pourcher, Céline Louapre |
| 6 |
[GO] |
2023―Apr―25 |
Low protection from breakthrough SARS-CoV-2 infection and mild disease course in ocrelizumab-treated patients with multiple sclerosis after three mRNA vaccine doses |
Frederik Novak, Hamza Mahmood Bajwa, John Eugenio Coia, Anna Christine Nilsson, Christian Nielsen, Dorte K Holm, Kamilla Østergaard, Mathilde Vilhelmine Miller Hvidt, Keld-Erik Byg, Isik S Johansen, Kristen Mittl, William Rowles, Scott S Zamvil, Riley Bove, Joseph J Sabatino, Tobias Sejbaek |
| 7 |
[GO] |
2023―Apr―07 |
Correspondence on functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines |
Amnuay Kleebayoon, Viroj Wiwanitkit |
| 8 |
[GO] |
2023―Mar―08 |
Functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines: a national multicentre observational study |
Araceli Alonso-Canovas, Monica M Kurtis, Victor Gomez-Mayordomo, Daniel Macías-García, Álvaro Gutiérrez Viedma, Elisabet Mondragón Rezola, Javier Pagonabarraga, Lidia Aranzabal Orgaz, Jaime Masjuan, Juan Carlos Martinez-Castrillo, Isabel Pareés |
| 9 |
[GO] |
2023―Jan―03 |
Humoral and cellular responses to SARS-CoV-2 vaccination in patients with autoantibody-mediated neuroimmunology |
Keigo Kihara, Makoto Kinoshita, Tomoyuki Sugimoto, Shuhei Okazaki, Hisashi Murata, Shohei Beppu, Naoyuki Shiraishi, Yasuko Sugiyama, Toru Koda, Tatsusada Okuno, Hideki Mochizuki |
| 10 |
[GO] |
2022―Dec―23 |
SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis |
Zoé L E van Kempen, Eileen W Stalman, Maurice Steenhuis, Laura Y L Kummer, Koos P J van Dam, Maarten F Wilbrink, Anja ten Brinke, S Marieke van Ham, Taco Kuijpers, Theo Rispens, Filip Eftimov, Luuk Wieske, Joep Killestein |
| 11 |
[GO] |
2022―Dec―17 |
10 What can we learn from the nervous sequelae of past pandemics? |
Mark Honigsbaum |
| 12 |
[GO] |
2022―Dec―15 |
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapies |
Alessandra Aiello, Andrea Coppola, Serena Ruggieri, Chiara Farroni, Anna Maria Gerarda Altera, Andrea Salmi, Valentina Vanini, Gilda Cuzzi, Linda Petrone, Silvia Meschi, Daniele Lapa, Aurora Bettini, Shalom Haggiag, Luca Prosperini, Simonetta Galgani, Maria Esmeralda Quartuccio, Nazario Bevilacqua, Anna Rosa Garbuglia, Chiara Agrati, Vincenzo Puro, Carla Tortorella, Claudio Gasperini, Emanuele Nicastri, Delia Goletti |
| 13 |
[GO] |
2022―Sep―22 |
Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations |
Domenico Plantone, Sara Locci, Laura Bergantini, Carlo Manco, Rosa Cortese, Martina Meocci, Dalila Cavallaro, Miriana d'Alessandro, Elena Bargagli, Nicola De Stefano |
| 14 |
[GO] |
2022―Aug―25 |
Somatic symptom disorder in patients with post-COVID-19 neurological symptoms: a preliminary report from the somatic study (Somatic Symptom Disorder Triggered by COVID-19) |
Alexandra Kachaner, Cédric Lemogne, Julie Dave, Brigitte Ranque, Thomas de Broucker, Elodie Meppiel |
| 15 |
[GO] |
2022―Aug―12 |
Epilepsy mortality in Wales during COVID-19 |
Helen Daniels, Arron S Lacey, David Mikadze, Ashley Akbari, Beata Fonferko-Shadrach, Joe Jolling-Hurst, Mark I Rees, Robert H Powell, Michael P Kerr, William Owen Pickrell |
| 16 |
[GO] |
2022―Aug―12 |
200 Covid-19 and acute ischaemic strokes in CADASIL: a systematic review of the literature |
Yassine Noui, Owain Williams, Nathan Chan, Julie Chandra, Laszlo Sztriha |
| 17 |
[GO] |
2022―Aug―12 |
203 A case of post COVID-19 endotheliitis |
Timothy Prossor, Gerolemos Christofi |
| 18 |
[GO] |
2022―Aug―12 |
110 Outcome and mortality of hospital admission with COVID-19 for individuals with parkinsonian syndromes |
Lexy Sorrell, Angela King, Jemma Inches, Jane Rideout, Robert Sneyd, Christopher Kobylecki, Ray Chaudhuri, Richard Walker, Hannah Martin, Camille Carroll |
| 19 |
[GO] |
2022―Aug―12 |
016 The evolution of neurological admissions preceding and during the Covid-19 pandemic |
Prisca Singh, Ghaniah Hassan-Smith |
| 20 |
[GO] |
2022―Aug―12 |
027 Patient reported experience of acute neurology telephone clinics during COVID-19 pandemic |
Kit Wu, Anna Alexandratou, Rahma Beyrouti, Pubudu Amarasena, Rachel King, Rob Weeks |
| 21 |
[GO] |
2022―Aug―12 |
127 Effect of reduced blood monitoring frequency in patients on dimethyl fumarate during the COVID-19 pandemic |
David Vaughan, Obioma Orazulume, Magnus Fugger, Wallace Brownlee |
| 22 |
[GO] |
2022―Aug―12 |
012 Neurological signs in a general neurology face to face clinic during the Covid-19 pandemic |
Udo Wieshmann |
| 23 |
[GO] |
2022―Aug―12 |
048 Impact of the COVID-19 pandemic on Creutzfeldt-Jakob disease surveillance and patient care in the UK |
Neil Watson, Jack Kirby, Hatice Kurudzhu, Margaret Leitch, Janet MacKenzie, Blaire Smith-Bathgate, Colin Smith, David Summers, Alison Green, Suvankar Pal |
| 24 |
[GO] |
2022―Aug―12 |
030 Post COVID-19 syndrome dysautonomia: a tertiary referral centre experience |
Sean Apap Mangion, Grace Oommen, Ekawat VIchayanrat, Melissa Heightman, Toby Hillman, Robert Bell, Ellen Merete Hagen, Gordon Ingle, Patricia McNamara, Valeria Iodice |
| 25 |
[GO] |
2022―Aug―12 |
COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database |
Ryan YS Keh, Sophie Scanlon, Katherine Donegan, Sally Cavanagh, Mark Foster, David Skelland, James Palmer, Pedro M Machado, Aisling S Carr, Michael P Lunn |
| 26 |
[GO] |
2022―Aug―12 |
Effectiveness of COVID-19 vaccines in multiple sclerosis patients receiving disease-modifying therapies in England |
Afagh Garjani, Sameer Patel, Graham R Law, Dhiren Bharkhada, Waqar Rashid, Alasdair Coles, Nikos Evangelou |
| 27 |
[GO] |
2022―Aug―12 |
Prevention of neurological complications during COVID-19: a retrospective analysis of the ISARIC4C national cohort |
Alexander Grundmann, Marc Hardwick, Chieh-Hsi Wu, Malcolm Semple, Dankmar Böhning, Sarah Pett, Benedict Michael, Rhys Thomas, Ian Galea |
| 28 |
[GO] |
2022―Aug―12 |
Acute inflammatory CNS diseases following vaccination against SARS-CoV-2 |
Anna Francis, Valentina Camera, Kariem Elhadd, Matthew Craner, Katherine Attfield, Astrid Iversen, Saif Huda, Lars Fugger, Jacqueline Palace |
| 29 |
[GO] |
2022―Aug―12 |
126 The provision of anti-CD20 therapy in inflammatory demyelinating disorders of the CNS during SARS-CoV-2 |
Imogen Smedley, Jonathan O’Riordan |
| 30 |
[GO] |
2022―Aug―12 |
003 A case of SARS-CoV-2 Omicron variant associated acute encephalomyelitis |
Michelle Dsouza, Nicole Lichtblau, Sarah Siddiqui, Sreedharan Harikrishnan, Nidal Abukhayzaran, Samuel Moses, Kristina Lauckaite |
| 31 |
[GO] |
2022―Aug―12 |
118 Acute disseminated encephalomyelitis associated with SARS-CoV-2 vaccine in multiple sclerosis: a case report |
Matthew Evans, Georgina Hanbury, Emma Lim, Luke Dixon, Victoria Singh-Curry, Richard Nicholas |
| 32 |
[GO] |
2022―Aug―12 |
021 Experience from a SARS-CoV2 neurology clinic at the national hospital of neurology and neurosurgery |
Simeona Jacinto, Alex Berry, Viva Levee, Melissa Heightman, Toby Hillman, Valeria Iodice, Lisa Cipolotti, Hadi Manji, Michael S Zandi, Patricia Mc Namara |
| 33 |
[GO] |
2022―Aug―12 |
023 Impact of pandemic on neurologists and neurology practice |
Christopher Kipps, Catherine Mummery |
| 34 |
[GO] |
2022―Aug―11 |
Comorbidity of long COVID and psychiatric disorders after a hospitalisation for COVID-19: a cross-sectional study |
Matthieu Gasnier, Walid Choucha, Francois Radiguer, Theo Faulet, Kenneth Chappell, Aurore Bougarel, Christian Kondarjian, Paul Thorey, Antoine Baldacci, Maryne Ballerini, Abd El Kader Ait Tayeb, Hugo Herrero, Isabelle Hardy-Leger, Olivier Meyrignac, Luc Morin, Anne-Lise Lecoq, Tài Pham, Nicolas Noel, Fabrice Jollant, David Montani, Xavier Monnet, Laurent Becquemont, Emmanuelle Corruble, Romain Colle |
| 35 |
[GO] |
2022―Jul―28 |
Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up |
|
| 36 |
[GO] |
2022―Jul―14 |
SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod |
Lil Meyer-Arndt, Julian Braun, Florent Fauchere, Kanika Vanshylla, Lucie Loyal, Larissa Henze, Beate Kruse, Manuela Dingeldey, Karsten Jürchott, Maike Mangold, Ardit Maraj, Andre Braginets, Chotima Böttcher, Andreas Nitsche, Kathrin de la Rosa, Christoph Ratswohl, Birgit Sawitzki, Pavlo Holenya, Ulf Reimer, Leif E Sander, Florian Klein, Friedemann Paul, Judith Bellmann-Strobl, Andreas Thiel, Claudia Giesecke-Thiel |
| 37 |
[GO] |
2022―Jun―14 |
Parsonage-Turner syndrome following COVID-19 vaccination |
Young Gi Min, Jee-Eun Kim, Ji Young Hwang, Je-Young Shin, Jung-Joon Sung, Yoon-Ho Hong |
| 38 |
[GO] |
2022―Jun―10 |
Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis |
Masoud Etemadifar, Hosein Nouri, Maristella Pitzalis, Maria Laura Idda, Mehri Salari, Mahshid Baratian, Sepide Mahdavi, Amir Parsa Abhari, Nahad Sedaghat |
| 39 |
[GO] |
2022―May―27 |
041 Posterior reversible encephalopathy syndrome (PRES) in mild and severe COVID-19 |
Philip Hayton, Hisham Hamdalla |
| 40 |
[GO] |
2022―May―27 |
COVID-19 and multiple sclerosis: An updated report of the community-based longitudinal UK MS Register study |
Afagh Garjani, Rodden M Middleton, Graham R Law, Katherine Tuite-Dalton, Rachael Hunter, Roshan das Nair, Nikos Evangelou, Richard Nicholas |
| 41 |
[GO] |
2022―May―27 |
074 COVID-19 as a cause of coma in adult onset vanishing white matter disease |
Sara Leddy, Steven Barden, Nicholas Skipper, Romi Saha |
| 42 |
[GO] |
2022―May―27 |
096 COVID-19 in MS: clinically reported outcomes from the UK MS register |
Rod Middleton, Elaine Craig, William Rodgers, Katie Tuite-Dalton, Afagh Garjani, Nikos Evangelou, Rachael Hunter, Roshan DasNair, Richard Nicholas |
| 43 |
[GO] |
2022―May―27 |
126 A case report of the emergence of neurosarcoidosis after COVID-19 infection |
Rebecca Robinson, Adam Nelson, Stella Hughes, Michael Kinney |
| 44 |
[GO] |
2022―May―27 |
008 Association of COVID-19 infections with new-onset and breakthrough epileptic seizures |
Hardik Bhaskar, Neeraj Singh |
| 45 |
[GO] |
2022―May―27 |
067 Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension |
Mark Thaller, George Tsermoulas, Rosa Sun, Susan Mollan, Alexandra Sinclair |
| 46 |
[GO] |
2022―May―27 |
102 Translating logistical challenges into service improvement: MS infusional services during the covid-19 pandemic |
Stephen Ramsay, Fiona Magill, Glenn Cartmill, Grainne Goldsmith, Jon McKee, Fiona Kennedy, Aidan Droogan, Stella Hughes, Gavin McDonnell |
| 47 |
[GO] |
2022―May―27 |
097 Disability and quality of life changes in people with MS (pwMS) throughout the COVID-19 pandemic |
William Rodgers, Rod Middleton, James Witts, Brooke Lumicisi, Richard Nicholas |
| 48 |
[GO] |
2022―May―27 |
032 Improving access to inpatient ambulatory cardiac monitoring for acute stroke patients during the Covid-19 pandemic |
Harriet Jeffery, Elena Rivero Sanz, David Turner |
| 49 |
[GO] |
2022―May―27 |
083 The impact of the Covid-19 pandemic on neurology outpatients services at Watford General Hospital |
Mayu Teranaka, Harry Mitchell, Krista Farrell |
| 50 |
[GO] |
2022―May―27 |
079 The impact of the COVID-19 pandemic on the mental health of MND patients |
Abigail Gilchrist, Amina Chaouch, John Ealing, Hisham Hamdalla, Sharon Coen |
| 51 |
[GO] |
2022―May―27 |
081 Comparison of 100 remotely assessed neurology outpatients during the COVID-19 pandemic with a 2019 cohort |
James Pigott, Jacob McCammon, Arani Nitkunan |
| 52 |
[GO] |
2022―May―27 |
082 Experiences of remote consulting for neurologists and patients during the COVID-19 pandemic: a national survey |
Maria Stavrou, Lioutas Eva, Lioutas Joanna, Richard Davenport |
| 53 |
[GO] |
2022―May―27 |
089 COVID-19 vaccinations in multiple sclerosis: UK MS register participant survey |
Yun Huang, Aravindhan Baheerathan, Rodden Middleton, William Rodgers, Katherine Tuite Dalton, Richard Nicholas |
| 54 |
[GO] |
2022―May―27 |
039 Cerebral venous sinus thrombosis and COVID-19: causation or coincidence? |
James Crawford, Hannah Taylor, Hajira Iftikhar, David McKee, Amina Chaouch |
| 55 |
[GO] |
2022―May―27 |
Neurologic and radiographic findings associated with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) |
Omar Abdel-Mannan, Justin Penner, Jane Hassell, Ulrike Loebel, Sue Maillard, Mae Johnson, Ronit Pressler, Alasdair Bamford, Karyn Moshal, Yael Hacohen |
| 56 |
[GO] |
2022―May―27 |
103 Virtual multiple sclerosis (MS) clinics during a global pandemic: the patients’ perspective |
Stephen Ramsay, Niamh Turley, Fiona Magill, Grainne Goldsmith, Jon McKee, Fiona Kennedy, Aidan Droogan, Stella Hughes, Gavin McDonnell |
| 57 |
[GO] |
2022―May―23 |
Impact of tDCS on persistent COVID-19 olfactory dysfunction: a double-blind sham-controlled study |
Lucilla Vestito, Laura Mori, Carlo Trompetto, Diego Bagnasco, Rikki F Canevari, Marta Ponzano, Davide Subbrero, Ester Cecchella, Cristina Barbara, Piero Clavario, Fabio Bandini |
| 58 |
[GO] |
2022―Mar―10 |
Impact of the COVID-19 pandemic on the prescription of disease-modifying therapy for multiple sclerosis in England: a nationwide study |
Thomas Williams, Rhea Mishra, Brina Bharkhada, Aoife Shields, Rachel Dorsey, Jeremy Chataway, Wallace J Brownlee |
| 59 |
[GO] |
2022―Mar―04 |
Consider alternative causes before allocating acute ischaemic stroke to COVID-19 |
Josef Finsterer |
| 60 |
[GO] |
2022―Feb―22 |
Immune response to SARS-CoV-2 vaccination in relation to peripheral immune cell profiles among patients with multiple sclerosis receiving ocrelizumab |
Saskia Räuber, Melanie Korsen, Niklas Huntemann, Leoni Rolfes, Thomas Müntefering, Vera Dobelmann, Alexander M Hermann, Tristan Kölsche, Karin von Wnuck Lipinski, Christina B Schroeter, Christopher Nelke, Liesa Regner-Nelke, Jens Ingwersen, Marc Pawlitzki, Bianca Teegen, Michael Harry Barnett, Hans-Peter Hartung, Orhan Aktas, Philipp Albrecht, Bodo Levkau, Nico Melzer, Tobias Ruck, Sven G Meuth, David Kremer |
| 61 |
[GO] |
2022―Jan―25 |
Acute ischaemic stroke associated with SARS-CoV-2 infection in North America |
Adam A Dmytriw, Mahmoud Dibas, Kevin Phan, Aslan Efendizade, Ospel Johanna, Clemens Schirmer, Fabio Settecase, Manraj K S Heran, Anna Luisa Kühn, Ajit S Puri, Bijoy K Menon, Sanjeev Sivakumar, Askan Mowla, Daniel Vela-Duarte, Italo Linfante, Guilherme C Dabus, Robert W Regenhardt, Salvatore D'Amato, Joseph A Rosenthal, Alicia Zha, Nafee Talukder, Sunil A Sheth, Ameer E Hassan, Daniel L Cooke, Lester Y Leung, Adel M Malek, Barbara Voetsch, Siddharth Sehgal, Ajay K Wakhloo, Mayank Goyal, Hannah Wu, Jake Cohen, Sherief Ghozy, David Turkel-Parella, Zerwa Farooq, Justin Vranic, James D Rabinov, Christopher J Stapleton, Ramandeep Minhas, Vinodkumar Velayudhan, Zeshan Ahmed Chaudhry, Andrew Xavier, Maria Bres Bullrich, Sachin Pandey, Luciano A Sposato, Stephen A Johnson, Gaurav Gupta, Priyank Khandelwal, Latisha Ali, David S Liebeskind, Mudassir Farooqui, Santiago Ortega-Gutierrez, Fadi Nahab, Dinesh V Jillella, Karen Chen, Mohammad Ali Aziz-Sultan, Mohamad Abdalkader, Artem Kaliaev, Thanh N Nguyen, Diogo C Haussen, Raul G Nogueira, Israr Ul Haq, Osama O Zaidat, Emma Sanborn, Thabele M Leslie-Mazwi, Aman B Patel, James E Siegler, Ambooj Tiwari |
| 62 |
[GO] |
2021―Sep―29 |
Clinical and biological features of cerebral venous sinus thrombosis following ChAdOx1 nCov-19 vaccination |
Christina Crossette-Thambiah, Charis Pericleous, Namir Asmar, Joshua Bomsztyk, Amita Ranger, Abdul Shlebak, Saipriya Ramji, Soma Banerjee, Mike Laffan, Deepa J Arachchillage |
| 63 |
[GO] |
2021―Sep―28 |
Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app |
Kerstin Klaser, Ellen J Thompson, Long H Nguyen, Carole H Sudre, Michela Antonelli, Benjamin Murray, Liane S Canas, Erika Molteni, Mark S Graham, Eric Kerfoot, Liyuan Chen, Jie Deng, Anna May, Christina Hu, Andy Guest, Somesh Selvachandran, David A Drew, Marc Modat, Andrew T Chan, Jonathan Wolf, Tim D Spector, Alexander Hammers, Emma L Duncan, Sebastien Ourselin, Claire J Steves |
| 64 |
[GO] |
2021―Aug―18 |
Functional disorders after COVID-19 vaccine fuel vaccination hesitancy |
Alfonso Fasano, Antonio Daniele |
| 65 |
[GO] |
2021―Aug―18 |
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis |
Massimiliano Di Filippo, Cinzia Cordioli, Simona Malucchi, Pietro Annovazzi, Paola Cavalla, Valentina Torri Clerici, Paolo Ragonese, Viviana Nociti, Marta Radaelli, Alice Laroni, Fabio Buttari, Lorena Lorefice, Diana Ferraro, Alberto Gajofatto, Luca Prosperini, Roberta Fantozzi, Laura Boffa, Roberta Lanzillo, Marcello Moccia, Marinella Clerico, Giovanna De Luca, Valentina Tomassini, Massimiliano Calabrese, Angela Borrelli, Damiano Paolicelli, Giorgia Teresa Maniscalco, Paola Gazzola, Antonio Gallo, Claudio Solaro, Eleonora Cocco, Claudio Gasperini, Carla Tortorella |
| 66 |
[GO] |
2021―Aug―06 |
Considerations for causality assessment of neurological and neuropsychiatric complications of SARS-CoV-2 vaccines: from cerebral venous sinus thrombosis to functional neurological disorder |
Matt Butler, Arina Tamborska, Greta K Wood, Mark Ellul, Rhys H Thomas, Ian Galea, Sarah Pett, Bhagteshwar Singh, Tom Solomon, Thomas Arthur Pollak, Benedict D Michael, Timothy R Nicholson |
| 67 |
[GO] |
2021―Aug―05 |
Vaccination and multiple sclerosis in the era of the COVID-19 pandemic |
Tobias Monschein, Hans-Peter Hartung, Tobias Zrzavy, Michael Barnett, Nina Boxberger, Thomas Berger, Jeremy Chataway, Amit Bar-Or, Paulus Stefan Rommer, Uwe K. Zettl |
| 68 |
[GO] |
2021―Aug―02 |
Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders |
Céline Louapre, Michella Ibrahim, Elisabeth Maillart, Basma Abdi, Caroline Papeix, Bruno Stankoff, Anne-Laure Dubessy, Caroline Bensa-Koscher, Alain Créange, Zina Chamekh, Catherine Lubetzki, Anne-Geneviève Marcelin, Jean-Christophe Corvol, Valérie Pourcher |
| 69 |
[GO] |
2021―Jul―16 |
7 Covid-19 and neuropsychiatry |
Benedict D Michael |
| 70 |
[GO] |
2021―Jul―16 |
#3125 Novel framework for neurocognitive COVID-19 assessment |
Jai Mathur, Alan Carson |
| 71 |
[GO] |
2021―Jul―16 |
#3123 Assessing international alcohol and internet use patterns during COVID-19 isolation using an online survey: highlighting distinct stressors conferring risk to compulsive behaviours |
Samantha N Sallie, Valentin JE Ritou, Henrietta Bowden-Jones, Valerie Voon |
| 72 |
[GO] |
2021―Jul―14 |
Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine |
Guendalina Beatrice Bonifacio, Dharmini Patel, Sarah Cook, Elena Purcaru, Michael Couzins, Janine Domjan, Suzanne Ryan, Ahmad Alareed, Orla Tuohy, Sean Slaght, Julian Furby, David Allen, Haider A Katifi, Lucy Kinton |
| 73 |
[GO] |
2021―Jun―04 |
Neurology and neuropsychiatry of COVID-19: a systematic review and
meta-analysis of the early literature reveals frequent CNS manifestations
and key emerging narratives |
Jonathan P Rogers, Cameron J Watson, James Badenoch, Benjamin Cross, Matthew Butler, Jia Song, Danish Hafeez, Hamilton Morrin, Emma Rachel Rengasamy, Lucretia Thomas, Silviya Ralovska, Abigail Smakowski, Ritika Dilip Sundaram, Camille Kaitlyn Hunt, Mao Fong Lim, Daruj Aniwattanapong, Vanshika Singh, Zain Hussain, Stuti Chakraborty, Ella Burchill, Katrin Jansen, Heinz Holling, Dean Walton, Thomas A Pollak, Mark Ellul, Ivan Koychev, Tom Solomon, Benedict Daniel Michael, Timothy R Nicholson, Alasdair G Rooney |
| 74 |
[GO] |
2021―May―26 |
Ischaemic stroke can follow COVID-19 vaccination but is much more common with COVID-19 infection itself |
Hugh S Markus |
| 75 |
[GO] |
2021―May―26 |
Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopaenia |
Talal Al-Mayhani, Sadia Saber, Matthew J Stubbs, Nicholas A Losseff, Richard J Perry, Robert J Simister, David Gull, Hans Rolf Jäger, Marie A Scully, David J Werring |
| 76 |
[GO] |
2021―Apr―27 |
Neurological diseases and risk of mortality in patients with COVID-19 and SARS: a territory-wide study in Hong Kong |
Florence Sin Ying Fan, Terry C F Yip, Brian Yiu, Bonnie Lam, Lisa Au, Alexander Yuk-lun Lau, Bonaventure Ip, Yannie Soo, Thomas W Leung, Timothy Li, Grace Lui, Grace L H Wong, Vincent Mok |
| 77 |
[GO] |
2021―Apr―21 |
Hypothyroidism is associated with prolonged COVID-19-induced anosmia: a case-control study |
Georgios Tsivgoulis, Paraskevi C. Fragkou, Emmanouil Karofylakis, Maria Paneta, Konstantinos Papathanasiou, Lina Palaiodimou, Constantin Psarros, Matilda Papathanasiou, Stefanos Lachanis, Petros P. Sfikakis, Sotirios Tsiodras |
| 78 |
[GO] |
2021―Mar―12 |
Correction: Ischaemic stroke associated with COVID-19 and racial outcome disparity in North America |
|
| 79 |
[GO] |
2020―Dec―24 |
Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension |
Mark Thaller, Georgios Tsermoulas, Rosa Sun, Susan P Mollan, Alexandra J Sinclair |
| 80 |
[GO] |
2020―Nov―20 |
Pattern of cognitive deficits in severe COVID-19 |
Valérie Beaud, Sonia Crottaz-Herbette, Vincent Dunet, Julien Vaucher, Raphaël Bernard-Valnet, Renaud Du Pasquier, Pierre-Alexandre Bart, Stephanie Clarke |
| 81 |
[GO] |
2020―Nov―06 |
Epileptiform activity and seizures in patients with COVID-19 |
Fabiane Santos de Lima, Naoum Issa, Kaitlin Seibert, Jared Davis, Richard Wlodarski, Sara Klein, Faten El Ammar, Shasha Wu, Sandra Rose, Peter Warnke, James Tao |
| 82 |
[GO] |
2020―Nov―06 |
Characteristics and outcomes of COVID-19-associated stroke: a UK multicentre case-control study |
Richard J Perry, Craig J Smith, Christine Roffe, Robert J Simister, Saravanan Narayanamoorthi, Richard Marigold, Mark Willmot, Anand Dixit, Ahamad Hassan, Terry Quinn, Sandeep Ankolekar, Liqun Zhang, Soma Banerjee, Urwah Ahmed, Nishita Padmanabhan, Phillip Ferdinand, Frances McGrane, Azra Banaras, Isobel H Marks, David J Werring |
| 83 |
[GO] |
2020―Nov―06 |
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions |
Massimiliano Filosto, Stefano Cotti Piccinelli, Stefano Gazzina, Camillo Foresti, Barbara Frigeni, Maria Cristina Servalli, Maria Sessa, Giuseppe Cosentino, Enrico Marchioni, Sabrina Ravaglia, Chiara Briani, Francesca Castellani, Gabriella Zara, Francesca Bianchi, Ubaldo Del Carro, Raffaella Fazio, Massimo Filippi, Eugenio Magni, Giuseppe Natalini, Francesco Palmerini, Anna Maria Perotti, Andrea Bellomo, Maurizio Osio, Giuseppe Scopelliti, Marinella Carpo, Andrea Rasera, Giovanna Squintani, Pietro Emiliano Doneddu, Valeria Bertasi, Maria Sofia Cotelli, Laura Bertolasi, Gian Maria Fabrizi, Sergio Ferrari, Federico Ranieri, Francesca Caprioli, Elena Grappa, Laura Broglio, Giovanni De Maria, Ugo Leggio, Loris Poli, Frank Rasulo, Nicola Latronico, Eduardo Nobile-Orazio, Alessandro Padovani, Antonino Uncini |
| 84 |
[GO] |
2020―Oct―29 |
Ischaemic strokes associated with COVID-19: is there a specific pattern? |
Edouard Januel, Laure Bottin, Marion Yger, Anne Leger, Sophie Crozier, Flore Baronnet, Sandrine Deltour, Stephen Delorme, Jean Capron, Alaina Borden, Beatrice Marro, Frédéric Clarençon, Nader Antoine Sourour, Yves Samson, Charlotte Rosso, Sonia Alamowitch |
| 85 |
[GO] |
2020―Oct―28 |
Intravenous thrombolysis for acute ischaemic stroke during COVID-19 pandemic in Wuhan, China: a multicentre, retrospective cohort study |
Yifan Zhou, Candong Hong, Jiang Chang, Yuanpeng Xia, Huijuan Jin, Yanan Li, Ling Mao, Yong Wang, Lei Zhang, Chunlian Pan, Jichuan Hu, Ming Huang, David Wang, Shengcai Chen, Bo Hu |
| 86 |
[GO] |
2020―Oct―14 |
COVID-19 impact on consecutive neurological patients admitted to the emergency department |
Andrea Pilotto, Alberto Benussi, Ilenia Libri, Stefano Masciocchi, Loris Poli, Enrico Premi, Antonella Alberici, Enrico Baldelli, Sonia Bonacina, Laura Brambilla, Matteo Benini, Salvatore Caratozzolo, Matteo Cortinovis, Angelo Costa, Stefano Cotti Piccinelli, Elisabetta Cottini, Viviana Cristillo, Ilenia Delrio, Massimiliano Filosto, Massimo Gamba, Stefano Gazzina, Nicola Gilberti, Stefano Gipponi, Marcello Giunta, Alberto Imarisio, Paolo Liberini, Martina Locatelli, Francesca Schiano, Ranata Rao, Barbara Risi, Luca Rozzini, Andrea Scalvini, Veronica Vergani, Irene Volonghi, Nicola Zoppi, Barbara Borroni, Mauro Magoni, Matilde Leonardi, Gianluigi Zanusso, Sergio Ferrari, Sara Mariotto, Alessandro Pezzini, Roberto Gasparotti, Ciro Paolillo, Alessandro Padovani |
| 87 |
[GO] |
2020―Sep―18 |
Increased ethnicity and socioeconomic data collection required in stroke associated with COVID-19 |
Danish Hafeez, Jia Song, Cameron Watson, Alasdair Rooney, Timothy R Nicholson |
| 88 |
[GO] |
2020―Aug―28 |
Antiganglioside antibodies in Guillain-Barré syndrome associated with SARS-CoV-2 infection |
Carlo Civardi, Alessandra Collini, Dinha Joan Geda, Claudio Geda |
| 89 |
[GO] |
2020―Aug―27 |
Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology |
Luke Dixon, Charles Coughlan, Kushan Karunaratne, Nikolaos Gorgoraptis, James Varley, James Husselbee, Dermot Mallon, Roseita Carroll, Brynmor Jones, Claire Boynton, Jane Pritchard, Taryn Youngstein, Justin Mason, Carolyn Gabriel |
| 90 |
[GO] |
2020―Aug―27 |
Self-diagnosed COVID-19 in people with multiple sclerosis: a community-based cohort of the UK MS Register |
Nikos Evangelou, Afagh Garjani, Roshan dasNair, Rachael Hunter, Katherine A Tuite-Dalton, Elaine M Craig, William J Rodgers, Alasdair Coles, Ruth Dobson, Martin Duddy, David Vincent Ford, Stella Hughes, Owen Pearson, Linda A Middleton, David Rog, Emma Clare Tallantyre, Tim Friede, Rodden M Middleton, Richard Nicholas |
| 91 |
[GO] |
2020―Aug―27 |
High mortality rate in COVID-19-associated stroke, analysis of risk factors |
Leonardo Renieri |
| 92 |
[GO] |
2020―Aug―27 |
Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic |
Antonino Uncini, Jean-Michel Vallat, Bart C Jacobs |
| 93 |
[GO] |
2020―Aug―14 |
Ischaemic stroke associated with COVID-19 and racial outcome disparity in North America |
Adam A Dmytriw, Kevin Phan, Clemens Schirmer, Fabio Settecase, Manraj K S Heran, Aslan Efendizade, Anna Luisa Kühn, Ajit S Puri, Bijoy K Menon, Mahmoud Dibas, Sanjeev Sivakumar, Askan Mowla, Lester Y Leung, Adel M Malek, Barbara Voetsch, Siddharth Sehgal, Ajay K Wakhloo, Hannah Wu, Andrew Xavier, Ambooj Tiwari |
| 94 |
[GO] |
2020―Jul―30 |
Guillain-Barré syndrome in times of pandemics |
Sonja E Leonhard, David R Cornblath, Hubert P Endtz, James J Sejvar, Bart C Jacobs |
| 95 |
[GO] |
2020―Jul―27 |
Posterior reversible encephalopathy syndrome associated with SARS-CoV-2 infection |
Abdenour Djellaoui, Lilia Seddik, Laurent Cleret De Langavant, Samuel Cattan, Anne Catherine Bachoud-Lévi, Hassan Hosseini |
| 96 |
[GO] |
2020―Jul―20 |
Status of SARS-CoV-2 in cerebrospinal fluid of patients with COVID-19 and stroke |
Fadi Al Saiegh, Ritam Ghosh, Adam Leibold, Michael B Avery, Richard F Schmidt, Thana Theofanis, Nikolaos Mouchtouris, Lucas Philipp, Stephen C Peiper, Zi-Xuan Wang, Fred Rincon, Stavropoula I Tjoumakaris, Pascal Jabbour, Robert H Rosenwasser, M. Reid Gooch |
| 97 |
[GO] |
2020―Jul―20 |
Psychological impact on women health workers involved in COVID-19 outbreak in Wuhan: a cross-sectional study |
Guo Li, Jinfeng Miao, Hui Wang, Shabei Xu, Wenzhe Sun, Yebin Fan, Chenyan Zhang, Suiqiang Zhu, Zhou Zhu, Wei Wang |
| 98 |
[GO] |
2020―Jul―13 |
A case of limbic encephalitis associated with asymptomatic COVID-19 infection |
Laura Zambreanu, Sophie Lightbody, Mohit Bhandari, Chandrashekar Hoskote, Hala Kandil, Catherine F Houlihan, Michael P Lunn |
| 99 |
[GO] |
2020―Jul―10 |
COVID-19-associated acute necrotising encephalopathy successfully treated with steroids and polyvalent immunoglobulin with unusual IgG targeting the cerebral fibre network |
Louis Delamarre, Cédric Gollion, Gaspard Grouteau, David Rousset, Guillaume Jimena, Jérôme Roustan, François Gaussiat, Etienne Aldigé, Charlène Gaffard, Julien Duplantier, Charlotte Martin, Olivier Fourcade, Chloé Bost, Françoise Fortenfant, Pierre Delobel, Guillaume Martin-Blondel, Jérémie Pariente, Fabrice Bonneville, Thomas Geeraerts |
| 100 |
[GO] |
2020―Jul―10 |
Management of patients with generalised myasthenia gravis and COVID-19: four case reports |
Annemarie Hübers, Agustina M Lascano, Patrice H Lalive |
| 101 |
[GO] |
2020―Jul―07 |
Postinfectious brainstem encephalitis associated with SARS-CoV-2 |
Anthony Khoo, Benjamin McLoughlin, Sanjay Cheema, Rimona S Weil, Christian Lambert, Hadi Manji, Michael S Zandi, Jasper M Morrow |
| 102 |
[GO] |
2020―Jun―23 |
Nervous system: subclinical target of SARS-CoV-2 infection |
Sara Mariotto, Alessia Savoldi, Katia Donadello, Serena Zanzoni, Silvia Bozzetti, Sara Carta, Cecilia Zivelonghi, Daniela Alberti, Francesco Piraino, Pietro Minuz, Domenico Girelli, Ernesto Crisafulli, Simone Romano, Denise Marcon, Giacomo Marchi, Leonardo Gottin, Enrico Polati, Paolo Zanatta, Salvatore Monaco, Evelina Tacconelli, Sergio Ferrari |
| 103 |
[GO] |
2020―Jun―05 |
Defining causality in COVID-19 and neurological disorders |
Mark Ellul, Aravinthan Varatharaj, Timothy R Nicholson, Thomas Arthur Pollak, Naomi Thomas, Ava Easton, Michael S Zandi, Hadi Manji, Tom Solomon, Alan Carson, Martin R Turner, Rachel Kneen, Ian Galea, Sarah Pett, Rhys Huw Thomas, Benedict Daniel Michael |
| 104 |
[GO] |
2020―Apr―30 |
Characteristics of ischaemic stroke associated with COVID-19 |
Rahma Beyrouti, Matthew E Adams, Laura Benjamin, Hannah Cohen, Simon F Farmer, Yee Yen Goh, Fiona Humphries, Hans Rolf Jäger, Nicholas A Losseff, Richard J Perry, Sachit Shah, Robert J Simister, David Turner, Arvind Chandratheva, David J Werring |
| 105 |
[GO] |
2020―Apr―20 |
Neurology in the time of covid-19 |
Hadi Manji, Aisling S Carr, Wallace J Brownlee, Michael P Lunn |
| 106 |
[GO] |
2020―Apr―20 |
Neurological manifestations of the coronavirus (SARS-CoV-2) pandemic 2019-2020 |
Kaiming Liu, Mengxiong Pan, Zheman Xiao, Xiaopei Xu |
|
